Rosiglitazone and poiglitazone
Enhance insulin effect on muscle, fat, liver without increasing pancreatic insulin secretion
Protein bound and hepatic metabolism - avoid in patients with liver disease
Side effects- induces ovulation, decreases effectiveness of OCP's, increases plasma volume (bad if CHF)
Diabetes medications
CHF medications
Diabetes mellitus 
Tono-Pen use
Hypertension 
Drugs of abuse
Intravenous drug use
Metformin